Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Persson

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
British Journal of Clinical Pharmacology|August 12, 2015
Antisense-mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first-in-human randomized, placebo-controlled trialEveline P van Poelgeest, Michael R Hodges, Matthijs Moerland, et al.
Drug Discovery Today|October 10, 2017
Locked nucleic acid: modality, diversity, and drug discoveryPeter H Hagedorn, Robert Persson, Erik D Funder, et al.
Molecular Therapy. Nucleic Acids|June 3, 2018
Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In VivoHassan Javanbakht, Henrik Mueller, Johanna Walther, et al.
The New England Journal of Medicine|March 29, 2013
Treatment of HCV infection by targeting microRNAHarry L A Janssen, Hendrik W Reesink, Eric J Lawitz, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 27, 2017
From the Cover: The Minipig is a Suitable Non-Rodent Model in the Safety Assessment of Single Stranded OligonucleotidesAnnamaria Braendli-Baiocco, Matthias Festag, Kamille Dumong Erichsen, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
British Journal of Clinical Pharmacology|August 12, 2015
Antisense-mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first-in-human randomized, placebo-controlled trialEveline P van Poelgeest, Michael R Hodges, Matthijs Moerland, et al.
Drug Discovery Today|October 10, 2017
Locked nucleic acid: modality, diversity, and drug discoveryPeter H Hagedorn, Robert Persson, Erik D Funder, et al.
Molecular Therapy. Nucleic Acids|June 3, 2018
Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In VivoHassan Javanbakht, Henrik Mueller, Johanna Walther, et al.
The New England Journal of Medicine|March 29, 2013
Treatment of HCV infection by targeting microRNAHarry L A Janssen, Hendrik W Reesink, Eric J Lawitz, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 27, 2017
From the Cover: The Minipig is a Suitable Non-Rodent Model in the Safety Assessment of Single Stranded OligonucleotidesAnnamaria Braendli-Baiocco, Matthias Festag, Kamille Dumong Erichsen, et al.
Pageof 3